You mistook what I said, the mortality rate is dow

You mistook what I said, the mortality rate is down big time with Omicron, but there are more cases. The NYTimes wrote about the shortage of MAB's to treat the higher number of Omicron cases and the rise in the number of deaths because not all the cases were Omicron, some were Delta. Unfortunately, Brazil will suffer the same, more deaths in the short term even though the long term effect will be that Omicron brings the Pandemic to the endemic stage. This could lead to more patients in our trial in Brazil in the short as other MAB's run short in supply, even though the pandemic becomes endemic in the long term.

The NYTimes has deaths up 35% on a daily basis to 2,362 over the week, even though Omicron has peaked.

NYTimes

Quote:

---

Hospitals Scramble as Antibody Treatments Fail Against Omicron

The single remaining monoclonal antibody therapy effective against the variant is now in short supply in the U.S., imperiling an option that doctors and hospitals have relied on.

---